Long Term Debt Summary of ResMed Inc.

ResMed Inc.'s latest annual long term debt in 2024 was 697.31 Million USD , down -51.28% from previous year.
ResMed Inc.'s latest quarterly long term debt in 2024 FY was 697.31 Million USD , down -54.96% from previous quarter.
ResMed Inc. reported annual long term debt of 1.54 Billion USD in 2023, up 74.77% from previous year.
ResMed Inc. reported annual long term debt of 885.77 Million USD in 2022, up 16.84% from previous year.
ResMed Inc. reported quarterly long term debt of 1.46 Billion USD for 2024 Q1, down -5.57% from previous quarter.
ResMed Inc. reported quarterly long term debt of 1.35 Billion USD for 2024 Q2, down -9.97% from previous quarter.

Annual Long Term Debt Chart of ResMed Inc. (2024 - 1993)

Historical Annual Long Term Debt of ResMed Inc. (2024 - 1993)

Year	Long Term Debt	Long Term Debt Growth
2024	697.31 Million USD	-51.28%
2023	1.54 Billion USD	74.77%
2022	885.77 Million USD	16.84%
2021	758.13 Million USD	-40.12%
2020	1.26 Billion USD	0.57%
2019	1.25 Billion USD	366.27%
2018	269.98 Million USD	-74.97%
2017	1.07 Billion USD	23.27%
2016	875 Million USD	191.09%
2015	300.59 Million USD	-0.06%
2014	300.77 Million USD	39011.83%
2013	769 Thousand USD	-99.69%
2012	250.78 Million USD	150.78%
2011	100 Million USD	263.27%
2010	27.52 Million USD	-70.77%
2009	94.19 Million USD	0.43%
2008	93.78 Million USD	7.01%
2007	87.64 Million USD	-24.58%
2006	116.21 Million USD	97.19%
2005	58.93 Million USD	-47.96%
2004	113.25 Million USD	0.0%
2003	113.25 Million USD	-8.11%
2002	123.25 Million USD	-17.83%
2001	150 Million USD	0.0%
2000	- USD	0.0%
1999	- USD	0.0%
1998	- USD	-100.0%
1997	300 Thousand USD	-50.0%
1996	600 Thousand USD	-25.0%
1995	800 Thousand USD	100.0%
1994	400 Thousand USD	100.0%
1993	200 Thousand USD	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 FY	697.31 Million USD	-54.96%
2024 Q1	1.46 Billion USD	-5.57%
2024 Q2	1.35 Billion USD	-9.97%
2024 Q4	697.31 Million USD	-30.06%
2024 Q3	997.04 Million USD	-18.06%
2023 Q3	1.69 Billion USD	-11.33%
2023 FY	1.54 Billion USD	74.77%
2023 Q1	899.65 Million USD	1.57%
2023 Q2	1.9 Billion USD	111.99%
2023 Q4	1.54 Billion USD	-8.45%
2022 Q3	795.98 Million USD	-0.62%
2022 Q1	915.18 Million USD	20.72%
2022 Q2	800.94 Million USD	-12.48%
2022 FY	885.77 Million USD	16.84%
2022 Q4	885.77 Million USD	11.28%
2021 Q1	1.15 Billion USD	-8.72%
2021 FY	758.13 Million USD	-40.12%
2021 Q2	931.37 Million USD	-19.4%
2021 Q3	834.31 Million USD	-10.42%
2021 Q4	758.13 Million USD	-9.13%
2020 FY	1.26 Billion USD	0.57%
2020 Q2	1.36 Billion USD	7.29%
2020 Q3	1.47 Billion USD	7.69%
2020 Q4	1.26 Billion USD	-14.0%
2020 Q1	1.27 Billion USD	1.21%
2019 Q1	517.63 Million USD	91.73%
2019 Q3	1.32 Billion USD	11.63%
2019 Q2	1.18 Billion USD	129.02%
2019 Q4	1.25 Billion USD	-4.87%
2019 FY	1.25 Billion USD	366.27%
2018 Q1	1.01 Billion USD	-5.54%
2018 Q4	269.98 Million USD	-66.67%
2018 Q3	810 Million USD	640.31%
2018 FY	269.98 Million USD	-74.97%
2018 Q2	109.41 Million USD	-89.26%
2017 Q2	868.69 Million USD	-0.55%
2017 Q1	873.51 Million USD	-0.17%
2017 Q4	1.07 Billion USD	-7.68%
2017 FY	1.07 Billion USD	23.27%
2017 Q3	1.16 Billion USD	34.5%
2016 Q4	875 Million USD	100.87%
2016 FY	875 Million USD	191.09%
2016 Q2	400.59 Million USD	-19.98%
2016 Q1	500.58 Million USD	66.53%
2016 Q3	435.6 Million USD	8.74%
2015 Q1	375.7 Million USD	24.91%
2015 FY	300.59 Million USD	-0.06%
2015 Q2	449.66 Million USD	19.69%
2015 Q3	460.58 Million USD	2.43%
2015 Q4	300.59 Million USD	-34.74%
2014 FY	300.77 Million USD	39011.83%
2014 Q1	790 Thousand USD	2.73%
2014 Q3	395.78 Million USD	-9.18%
2014 Q4	300.77 Million USD	-24.01%
2014 Q2	435.79 Million USD	55063.8%
2013 Q2	300.79 Million USD	13.17%
2013 Q1	265.78 Million USD	5.98%
2013 Q4	769 Thousand USD	0.39%
2013 FY	769 Thousand USD	-99.69%
2013 Q3	766 Thousand USD	-99.75%
2012 Q3	235 Million USD	4.44%
2012 Q4	250.78 Million USD	6.72%
2012 Q2	225 Million USD	73.08%
2012 FY	250.78 Million USD	150.78%
2012 Q1	130 Million USD	30.0%
2011 FY	100 Million USD	263.27%
2011 Q2	64.35 Million USD	-31.39%
2011 Q3	80 Million USD	24.3%
2011 Q4	100 Million USD	25.0%
2011 Q1	93.8 Million USD	0.0%
2010 FY	27.52 Million USD	-70.77%
2010 Q2	94.59 Million USD	-0.52%
2010 Q1	95.09 Million USD	0.96%
2010 Q3	29.46 Million USD	-68.85%
2010 Q4	- USD	-100.0%
2009 Q4	94.19 Million USD	1.26%
2009 FY	94.19 Million USD	0.43%
2009 Q3	93.01 Million USD	8.98%
2009 Q2	85.35 Million USD	-21.32%
2009 Q1	108.48 Million USD	15.66%
2008 Q4	93.78 Million USD	-19.13%
2008 Q2	106.53 Million USD	17.66%
2008 Q1	90.54 Million USD	3.3%
2008 FY	93.78 Million USD	7.01%
2008 Q3	115.97 Million USD	8.86%
2007 Q4	87.64 Million USD	-8.59%
2007 FY	87.64 Million USD	-24.58%
2007 Q3	95.88 Million USD	0.8%
2007 Q2	95.12 Million USD	-17.63%
2007 Q1	115.48 Million USD	-0.63%
2006 Q2	58.18 Million USD	-0.73%
2006 Q3	94.28 Million USD	62.03%
2006 Q4	116.21 Million USD	23.26%
2006 FY	116.21 Million USD	97.19%
2006 Q1	58.61 Million USD	-0.54%
2005 Q4	58.93 Million USD	-47.96%
2005 Q3	113.25 Million USD	0.0%
2005 Q2	113.25 Million USD	0.0%
2005 Q1	113.25 Million USD	0.0%
2005 FY	58.93 Million USD	-47.96%
2004 FY	113.25 Million USD	0.0%
2004 Q4	113.25 Million USD	0.0%
2004 Q3	113.25 Million USD	0.0%
2004 Q2	113.25 Million USD	0.0%
2004 Q1	113.25 Million USD	0.0%
2003 Q3	113.25 Million USD	0.0%
2003 FY	113.25 Million USD	-8.11%
2003 Q2	113.25 Million USD	-4.23%
2003 Q1	118.25 Million USD	-4.06%
2003 Q4	113.25 Million USD	0.0%
2002 Q2	180 Million USD	0.0%
2002 Q3	146 Million USD	-18.89%
2002 Q4	123.25 Million USD	-15.58%
2002 FY	123.25 Million USD	-17.83%
2002 Q1	180 Million USD	20.0%
2001 Q2	- USD	0.0%
2001 Q1	- USD	0.0%
2001 FY	150 Million USD	0.0%
2001 Q4	150 Million USD	0.0%
2001 Q3	- USD	0.0%
2000 Q2	- USD	0.0%
2000 FY	- USD	0.0%
2000 Q1	- USD	0.0%
2000 Q4	- USD	0.0%
2000 Q3	- USD	0.0%
1999 Q3	- USD	0.0%
1999 FY	- USD	0.0%
1999 Q1	- USD	0.0%
1999 Q2	- USD	0.0%
1999 Q4	- USD	0.0%
1998 Q4	- USD	-100.0%
1998 FY	- USD	-100.0%
1998 Q2	- USD	-100.0%
1998 Q3	200 Thousand USD	0.0%
1998 Q1	300 Thousand USD	0.0%
1997 Q3	400 Thousand USD	0.0%
1997 FY	300 Thousand USD	-50.0%
1997 Q1	600 Thousand USD	0.0%
1997 Q2	400 Thousand USD	-33.33%
1997 Q4	300 Thousand USD	-25.0%
1996 FY	600 Thousand USD	-25.0%
1996 Q3	900 Thousand USD	0.0%
1996 Q4	600 Thousand USD	-33.33%
1995 FY	800 Thousand USD	100.0%
1995 Q4	800 Thousand USD	0.0%
1994 FY	400 Thousand USD	100.0%
1994 Q4	400 Thousand USD	0.0%
1993 Q4	200 Thousand USD	0.0%
1993 FY	200 Thousand USD	0.0%

Peer Long Term Debt Comparison of ResMed Inc.

Name	Long Term Debt	Long Term Debt Difference
Phreesia, Inc.	2.04 Million USD	-33931.869%
Accuray Incorporated	164.4 Million USD	-324.156%
Align Technology, Inc.	96.96 Million USD	-619.117%
Elevance Health Inc.	23.24 Billion USD	97.0%
AxoGen, Inc.	46.6 Million USD	-1396.284%
Boston Scientific Corporation	8.56 Billion USD	91.86%
CVS Health Corporation	74.67 Billion USD	99.066%
Cardinal Health, Inc.	4.58 Billion USD	84.785%
Centene Corporation	17.69 Billion USD	96.06%
DaVita Inc.	8.05 Billion USD	91.339%
HCA Healthcare, Inc.	36.62 Billion USD	98.096%
Hologic, Inc.	2.49 Billion USD	72.075%
Humana Inc.	10.21 Billion USD	93.172%
IDEXX Laboratories, Inc.	622.88 Million USD	-11.949%
Laboratory Corporation of America Holdings	4.05 Billion USD	82.802%
Masimo Corporation	871.7 Million USD	20.005%
McKesson Corporation	5.45 Billion USD	87.208%
Patterson Companies, Inc.	328.91 Million USD	-112.007%
Quest Diagnostics Incorporated	4.41 Billion USD	84.188%
Henry Schein, Inc.	1.93 Billion USD	63.926%
Teladoc Health, Inc.	1.58 Billion USD	55.909%
Universal Health Services, Inc.	4.71 Billion USD	85.214%
Veeva Systems Inc.	46.44 Million USD	-1401.503%
Baxter International Inc.	11.06 Billion USD	93.697%
Becton, Dickinson and Company	14.73 Billion USD	95.269%
Intuitive Surgical, Inc.	-82.1 Million USD	949.346%
Danaher Corporation	17.66 Billion USD	96.052%
Stryker Corporation	10.9 Billion USD	93.603%
Medtronic plc	23.87 Billion USD	97.08%

Global Stocks Search

ResMed Inc. (0KW4.L)

Long Term Debt Summary of ResMed Inc.

Annual Long Term Debt Chart of ResMed Inc. (2024 - 1993)

Historical Annual Long Term Debt of ResMed Inc. (2024 - 1993)

Peer Long Term Debt Comparison of ResMed Inc.